Global Tumor Ablation Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
Tumor Ablation Market Overview:
The Tumor Ablation Market was valued at $21.40 million in 2021 & is projected to reach $54.52 million by 2027. It is expected to grow at a 12.4% CAGR between 2021 and 2027.
The Tumor Ablation Market report offers in-depth insights, revenue details, and other vital information regarding the global tumor ablation market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.
The Tumor Ablation Market report offers insightful and detailed information regarding the various key players operating in the global tumor ablation market, their financials, supply chain trends, technological innovations, and key developments, apart from future strategies, acquisitions & mergers, and market footprint.
The global tumor ablation market report has been segmented on the basis of technology, mode of treatment, application, and region.
Tumor ablation is a technique used in the treatment of tumors in kidneys, liver, lungs, and bones. Tumor ablation is considered a first-line treatment for patients with small hepatocellular carcinomas or benign tumors in the liver.
In tumor ablation technique, microwave (MW), radio-frequency (RF), high-intensity focused ultrasound (HIFU) systems, or laser is used to heat tissue to at least 60°C for maximum efficacy and a cryoablation system is used to cool the tissue to less than −40°C to cause tissue necrosis.
An increasing number of cancer patients and technological advancements in tumor ablation devices on the basis of cost-effectiveness, portability, and accuracy are key factors driving the growth of the global tumor ablation market.
In addition, increasing awareness about tumor ablation techniques and a growing number of ablation centers are other major factors expected to boost the growth of the global tumor ablation market over the forecast period.
However, the shorter lifespan of devices and long approval time associated with product launch are key factors hampering the growth of the global tumor ablation market.
Additionally, side effects related to ablation treatment such as infection in the liver, bleeding into the chest cavity or abdomen, abdominal pain, and stringent government regulation are other major factors expected to hamper the growth of the global tumor ablation market over the forecast period.
The market in North America dominates the global tumor ablation market in terms of revenue followed by Europe, owing to rising government funding for cancer research and advanced healthcare infrastructure present in the region.
In terms of CAGR, the market in the Asia Pacific is projected to have the fastest growth in the global tumor ablation market over the forecast period. This can be attributed to the increasing prevalence of different cancers and growing healthcare expenditure in emerging economies in the region.
Global Tumor Ablation Market Segmentation:
Global tumor ablation market segmentation by technology:
- Radiofrequency (RF) Ablation
- Microwave Ablation
- Other Technologies
Global tumor ablation market segmentation by mode of treatment:
- Percutaneous Ablation
- Laparoscopic Ablation
- Surgical Ablation
Global tumor ablation market segmentation by application:
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
Global tumor ablation market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Boston Scientific Corporation
- Galil Medical Inc.
- EDAP TMS
- HealthTronics, Inc.
- Mermaid Medical A/S
- Ethicon US, LLC.
- SonaCare Medical, LLC.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!